AR038141A1 - Composiciones farmaceuticas estables que comprenden inhibidor(es) de ace - Google Patents
Composiciones farmaceuticas estables que comprenden inhibidor(es) de aceInfo
- Publication number
- AR038141A1 AR038141A1 ARP030100098A ARP030100098A AR038141A1 AR 038141 A1 AR038141 A1 AR 038141A1 AR P030100098 A ARP030100098 A AR P030100098A AR P030100098 A ARP030100098 A AR P030100098A AR 038141 A1 AR038141 A1 AR 038141A1
- Authority
- AR
- Argentina
- Prior art keywords
- ace inhibitor
- stable pharmaceutical
- pharmaceutical compositions
- include ace
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/556—Angiotensin converting enzyme inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Composiciones farmacéuticas estables que comprenden inhibidor(es) de ACE y otras sustancias farmacéuticamente activas que son susceptibles a la degradación, así como procesos para la preparación de las mismas y métodos de tratamiento que implican la administración de dichas composiciones. Reivindicación 1: Una composición farmacéutica estables para administración oral de inhibidor(es) de ACE que comprende un núcleo revestido con una capa de inhibidor(es) de ACE. Reivindicación 3: La composición de la reivindicación 1, en la cual el inhibidor de ACE se selecciona del grupo formado por ramipil, quinapril, enalapril, espirapril, lisinopril y benazepril.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN24DE2002 | 2002-01-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR038141A1 true AR038141A1 (es) | 2004-12-29 |
Family
ID=11097019
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP030100098A AR038141A1 (es) | 2002-01-15 | 2003-01-15 | Composiciones farmaceuticas estables que comprenden inhibidor(es) de ace |
Country Status (7)
Country | Link |
---|---|
US (1) | US20050202081A1 (es) |
EP (1) | EP1467717A1 (es) |
AR (1) | AR038141A1 (es) |
AU (1) | AU2003201071A1 (es) |
BR (1) | BR0306928A (es) |
MX (1) | MXPA04006892A (es) |
WO (1) | WO2003059330A1 (es) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0301471D0 (en) * | 2003-01-22 | 2003-02-19 | Biochemie Gmbh | Organic compounds |
GB2394660A (en) * | 2003-12-17 | 2004-05-05 | Niche Generics Ltd | Stabilisation of pharmaceutical compositions comprising ACE inhibitor by absence of acidic excipients having large specific surface area, eg silicon dioxide |
GB2411355B (en) * | 2004-02-27 | 2006-02-22 | Niche Generics Ltd | Pharmaceutical composition |
US20080234353A1 (en) * | 2004-03-24 | 2008-09-25 | Reynir Eyjolfsson | Formulations of Ramipril |
US7829720B2 (en) | 2004-05-04 | 2010-11-09 | Bristol-Myers Squibb Company | Process for preparing atazanavir bisulfate and novel forms |
TWI354569B (en) | 2004-05-28 | 2011-12-21 | Bristol Myers Squibb Co | Coated tablet formulation and method |
EP1813274B1 (en) * | 2004-10-06 | 2009-12-16 | Eisai R&D Management Co., Ltd. | Medicinal composition, process for producing the same, and method of stabilizing dihydropyridine compound in medicinal composition |
WO2006117803A2 (en) * | 2005-03-14 | 2006-11-09 | Devarajan, Padma, Venkitachalam | Transmucosal drug delivery systems |
GB0518129D0 (en) * | 2005-09-06 | 2005-10-12 | Arrow Int Ltd | Ramipril formulation |
GB2431579A (en) * | 2005-10-28 | 2007-05-02 | Arrow Int Ltd | Ramipril formulations |
US20070098782A1 (en) * | 2005-10-28 | 2007-05-03 | Selamine Limited | Ramipril Formulation |
WO2008001184A2 (en) * | 2006-06-26 | 2008-01-03 | Emcure Pharmaceuticals Limited | Solid composition |
GB0624084D0 (en) * | 2006-12-01 | 2007-01-10 | Selamine Ltd | Ramipril amino acid salts |
GB0624087D0 (en) * | 2006-12-01 | 2007-01-10 | Selamine Ltd | Ramipril combination salt |
GB0624090D0 (en) * | 2006-12-01 | 2007-01-10 | Selamine Ltd | Ramipril amine salts |
IT1393244B1 (it) | 2008-07-18 | 2012-04-12 | Universita' Degli Studi Di Milano | Sistema per il rilascio al colon di farmaci suscettibili di degradazione enzimatica e/o scarsamente assorbiti nel tratto gastrointestinale |
TR200906322A2 (tr) | 2009-08-17 | 2011-07-21 | Bi̇lgi̇ç Mahmut | Çözünürlük ve stabilite özellikleri geliştirilmiş granüller. |
ES2364011B1 (es) | 2009-11-20 | 2013-01-24 | Gp Pharm, S.A. | Cápsulas de principios activos farmacéuticos y ésteres de ácidos grasos poliinsaturados para el tratamiento de enfermedades cardiovasculares. |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3403329A1 (de) * | 1984-02-01 | 1985-08-01 | Horst Dr. 4019 Monheim Zerbe | Pharmazeutisches produkt in form von pellets mit kontinuierlicher, verzoegerter wirkstoffabgabe |
US4793998A (en) * | 1986-10-20 | 1988-12-27 | Warner-Lambert Company | Stabilized drug compositions |
US4830853A (en) * | 1986-10-20 | 1989-05-16 | Warner-Lambert Company | Drug compositions stabilized against oxidation |
US4743450A (en) * | 1987-02-24 | 1988-05-10 | Warner-Lambert Company | Stabilized compositions |
NZ226179A (en) * | 1987-09-24 | 1991-04-26 | Merck & Co Inc | Controlled porosity osmotic pump for sustained release of pharmaceutical agents |
DE3739690A1 (de) * | 1987-11-24 | 1989-06-08 | Hoechst Ag | Stabilisierte arzneistoffe, verfahren zu ihrer herstellung sowie stabile arzneizubereitungen |
US5158777A (en) * | 1990-02-16 | 1992-10-27 | E. R. Squibb & Sons, Inc. | Captopril formulation providing increased duration of activity |
TW483763B (en) * | 1994-09-02 | 2002-04-21 | Astra Ab | Pharmaceutical composition comprising of ramipril and dihydropyridine compound |
WO1998053802A1 (en) * | 1997-05-30 | 1998-12-03 | Laboratorios Phoenix U.S.A., Inc. | Multi-layered osmotic device |
US6569456B2 (en) * | 2000-01-13 | 2003-05-27 | Osmotica Corp. | Osmotic device containing diltiazem and an ACE inhibitor or diuretic |
-
2003
- 2003-01-14 BR BR0306928-1A patent/BR0306928A/pt not_active IP Right Cessation
- 2003-01-14 WO PCT/IB2003/000063 patent/WO2003059330A1/en not_active Application Discontinuation
- 2003-01-14 MX MXPA04006892A patent/MXPA04006892A/es not_active Application Discontinuation
- 2003-01-14 AU AU2003201071A patent/AU2003201071A1/en not_active Abandoned
- 2003-01-14 EP EP03729521A patent/EP1467717A1/en not_active Withdrawn
- 2003-01-14 US US10/501,450 patent/US20050202081A1/en not_active Abandoned
- 2003-01-15 AR ARP030100098A patent/AR038141A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
AU2003201071A1 (en) | 2003-07-30 |
MXPA04006892A (es) | 2004-10-15 |
US20050202081A1 (en) | 2005-09-15 |
BR0306928A (pt) | 2004-11-09 |
WO2003059330A1 (en) | 2003-07-24 |
EP1467717A1 (en) | 2004-10-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR038141A1 (es) | Composiciones farmaceuticas estables que comprenden inhibidor(es) de ace | |
EE05287B1 (et) | Tsklopentanoindoolid, nende kasutamine ravimi valmistamiseks ning neid sisaldav farmatseutiline kompositsioon | |
EA200800161A1 (ru) | Новые фармацевтические композиции с модифицированным высвобождением и способ получения таких композиций | |
EA200900264A1 (ru) | Композиции флибансерина и способ их приготовления | |
KR980000447A (ko) | 미르타자핀과 하나 이상의 선택적인 세로토닌 재이용 저해제로 이루어진 약학 조성물 | |
AR060019A1 (es) | Composicion farmaceutica, producto y metodo de tratamiento para un trastorno cognitivo y usos de un inhibidor de acetilcolinesterasa y un antagonista de 5- ht6 en la fabricacion de un medicamento para el tratamiento de un trastorno cognitivo | |
ES2733044T1 (es) | Composición farmacéutica que contiene oxicodona y naloxona | |
WO2005009357A3 (en) | Controlled release compositions | |
WO2005069933A3 (en) | Methods of treating an inflammatory-related disease | |
EA200701575A1 (ru) | Формуляция леветирацетама длительного высвобождения | |
UY28438A1 (es) | Composicion de un antagonista de vegf y de un agente antiproliferativo | |
WO2007062413A3 (en) | Use of parp-1 inhibitors | |
ATE374601T1 (de) | Multipartikuläre arzneiform, enthaltend mucoadhaesiv formulierte peptid- oder protein- wirkstoffe, sowie ein verfahren zur herstellung der arzneiform | |
HUP0000976A2 (hu) | Protonpumpa inhibitort tartalmazó, több egységből pezsgőtablettává préselt gyógyszeradagolási formák | |
DE602006021444D1 (de) | Therapie zur behandlung der überaktiven blase | |
BRPI0508579A (pt) | composto, composição farmacêutica, e, uso de um composto | |
AR025938A1 (es) | Nuevas composiciones farmaceuticas. | |
RU2015102772A (ru) | Бензодиазелипы для мелкоклеточного рака легкого | |
WO2005007072A3 (en) | Methods and pharmaceutical compositions for healing wounds | |
DE60108489D1 (de) | Kombinationstherapien mit gefässschädigender aktivität | |
DE50211566D1 (de) | Kombination ausgewählter opioide mit muscarin-antagonisten zur therapie der harninkontinenz | |
MX2008008413A (es) | Composicion farmaceutica para el tratamiento de las enfermedades de las uñas. | |
ATE429925T1 (de) | Methoden und pharmazeutische zusammensetzungen zur wundheilung | |
CU20090007A6 (es) | Un compuesto farmacéutico y un proceso del mismo | |
ECSP045110A (es) | Composiciones de la preparación que contiene un compuesto fisiologicamente activo de acidos inestables y procesos para su producción |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |